Target
Bromodomain-containing protein 3 [326-398]
Ligand
BDBM50092310
Substrate
n/a
Meas. Tech.
Biolayer Interferometry (BLI) Binding Assay
pH
7.4000±n/a
Kd
21±3.60 nM
Comments
extracted
Citation
 Wang, S; Ran, X; Zhao, Y; Yang, C; Liu, L; Bai, L; McEachern, D; Stuckey, J; Meagher, JL; Sun, D; Li, X; Zhou, B; Karatas, H; Luo, R; Chinnaiyan, A; Asangani, IA BET bromodomain inhibitors and therapeutic methods using the same US Patent  US9675697-B2 Publication Date 6/13/2017 
Target
Name:
Bromodomain-containing protein 3 [326-398]
Synonyms:
Bromodomain-containing protein 3 (BRD3)(BD2) | Bromodomain-containing protein 3 Bromo 2 domain(BRD3 BD2) | BRD3_HUMAN | BRD3 | KIAA0043 | RING3L
Type:
n/a
Mol. Mass.:
8553.07
Organism:
Human
Description:
BD2 (326-398 aa) of Q15059
Residue:
73
Sequence:
KHAAYAWPFYKPVDAEALELHDYHDIIKHPMDLSTVKRKMDGREYPDAQGFAADVRLMFSNCYKYNPPDHEVV
  
Inhibitor
Name:
BDBM50092310
Synonyms:
US9675697, Cpd. No. 23 | CHEMBL3581661
Type:
Small organic molecule
Emp. Form.:
C24H23N5O2
Mol. Mass.:
413.19
SMILES:
COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12
Structure:
Search PDB for entries with ligand similarity: